Abstract
The earliest genomic RNAs had to be short enough for efficient replication, while simultaneously serving as unfolded templates and effective ribozymes. A partial solution to this paradox may lie in the fact that many functional RNAs can self-assemble from multiple fragments. Therefore, in early evolution, genomic RNA fragments could have been significantly shorter than unimolecular functional RNAs. Here, we show that unstable, nonfunctional complexes assembled from even shorter 3′-truncated oligonucleotides can be stabilized and gain function via non-enzymatic primer extension. Such short RNAs could act as good templates due to their minimal length and complex-forming capacity, while their minimal length would facilitate replication by relatively inefficient polymerization reactions. These RNAs could also assemble into nascent functional RNAs and undergo conversion to catalytically active forms, by the same polymerization chemistry used for replication that generated the original short RNAs. Such phenomena could have substantially relaxed requirements for copying efficiency in early nonenzymatic replication systems.
Introduction
Prior to the evolution of protein-based enzymes, primitive cells are thought to have relied on RNA enzymes for catalysis.1−3 The hypothesis of such an early, RNA-dominated stage in the evolution of life is supported by the continued existence of ribozymes in modern biology,4,5 and especially by the observation that protein synthesis is catalyzed by the RNA component of the large ribosomal subunit.6 In addition to this evidence, ribozymes obtained by in vitro directed evolution can catalyze a wide variety of reactions, encompassing all of the basic classes of transformations necessary for protocell metabolism and reproduction.7,8 However, the origins of RNA-based protocells remain unclear, and numerous problems must be solved to establish an understanding of how prebiotic chemical systems gave rise to protocells containing both replicating genomic RNAs and functional ribozymes derived from those genomic RNAs.
One of the central problems faced by the earliest cells is likely to have been the slow and inefficient nature of primordial RNA replication. Indeed, prior to the evolution of a sophisticated RNA replicase ribozyme, protocells may have had to rely on the ambient chemical environment to drive non-enzymatic RNA replication. Efforts to demonstrate prebiotically plausible RNA replication chemistry date back some four decades,9 but despite recent progress,10−13 several obstacles remain.14 At present, non-enzymatic RNA polymerization allows for the partial copying of short RNA templates. In model studies, the growing RNA primer strand is elongated by addition of ribonucleotides activated with a good leaving group (e.g., 2-methylimidazole or hydroxyazabenzotriazole).15−17
In this paper, we assume that the unsolved obstacles to non-enzymatic RNA replication reflect our current lack of understanding, and are not insurmountable hurdles. However, we also expect that primitive, chemically driven RNA replication was only marginally sufficient for the emergence of protocells bearing small replicating fragments of RNA. We then ask: given such a situation, how could protocells bearing selectively advantageous, heritable ribozyme activities have emerged?
Ribozymes with a kcat of greater than 1 min–1 are generally at least 30 nucleotides in length and often 50–100 nucleotides long; the few known ribozymes with a kcat of greater than 1 s–1 are over 100 nucleotides in length.18−22 Generating RNAs of 50–100 nucleotides in length by non-enzymatic template-directed polymerization seems like a severe challenge. Fortunately, several previous reports have shown that such ribozymes can be reconstituted from shorter oligonucleotides by their assembly into a noncovalent complex that retains good catalytic activity.23−27 The minimal length of such oligonucleotides reflects the need for stable base-paired stems as the driving force for complex assembly. If each oligonucleotide is anchored in the complex by two or three stems of 5–6 nucleotides, with interspersed sequences of similar length forming binding or catalytic sites, then a minimal fragment length of 15–25 nucleotides would be reasonable. We, therefore, hypothesize that primitive cells contained a set of genomic oligonucleotides in this size range, all being replicated by non-enzymatic chemistry, with some of these oligonucleotides assembling into complexes with useful catalytic activities. If it were possible for even shorter genomic oligonucleotides to generate functional ribozyme complexes, the constraints on RNA replication chemistry would be correspondingly diminished.
Here we show that functional ribozymes can be reconstituted from oligonucleotides that have been further shortened by 3′-truncation. In this scenario, the 3′-truncated oligonucleotides assemble into unstable and inactive precursor complexes that are held together by very short unstable terminal stems. Non-enzymatic template-directed extension of the oligonucleotide 3′-termini, which act as primers, lengthens the initially short and unstable base-paired stems, generating stable complexes with good catalytic activity. Such extended oligonucleotides could be removed from the pool of replicating RNA fragments, as they would be locked into stable catalytic complexes. Non-extended genomic fragments would be easier to replicate, owing to both the comparative ease of copying short RNA sequences and the fact that they were not sequestered in stable complexes. This simple mechanism substantially relaxes the requirements for RNA replication systems, and it could have facilitated the transition from prebiotic chemical systems to evolving living cells.
Results
We studied an aptamer and a cis-acting ribozyme that could each be reconstituted by the assembly of two oligonucleotides into a functional complex, held together in part by terminal base-paired stems. We also studied a second, trans-acting ribozyme consisting of a single oligonucleotide, the active form of which required the formation of a base-paired stem between its 3′-terminus and an internal sequence. We then modified the structure of each of these oligonucleotides by shortening the 3′-end by 3 or 4 nucleotides; as a result, the 3′-truncated oligonucleotides were unable to assemble into functionally active complexes. However, these shortened oligonucleotides could assemble into transiently stable complexes, in which the oligonucleotide 3′-ends formed one or two base-pairs in the nascent stem. Such assembly resulted in a “primer–template” configuration, in which the 3′-end could be extended by non-enzymatic polymerization, thus generating an extended and, therefore, more stable base-paired stem. In each case, we were able to observe the recovery of ligand binding or catalytic activity following non-enzymatic template-directed primer extension (Figure 1).
Malachite Green Aptamer
An RNA aptamer that binds malachite green has been previously reported.28 We chose to work with this aptamer for an initial proof-of-principle of the hypothesis that 3′-truncated oligonucleotides can self-assemble into intermediate structures that can serve as templates for the reconstitution of functional RNAs. The free malachite green ligand has very low fluorescence, but its fluorescence increases by several orders of magnitude upon binding to the RNA aptamer.29 This is a convenient signal for the formation of a functional aptamer. In addition, the aptamer and its mode of ligand binding have been studied extensively.30 NMR studies indicate that the terminal base-paired stems form in the absence of ligand, but the central region of the aptamer folds around its ligand, and it becomes ordered only upon ligand binding. Thus, it seemed likely that the ability of the aptamer to fold and bind its ligand could be readily controlled by altering the length of its terminal stems. Additionally, this aptamer has been previously deconstructed into two oligonucleotides that can assemble into a functional complex.29
To demonstrate aptamer stabilization by non-enzymatic template-directed RNA synthesis, we modified the previously reported sequences of the two-fragment malachite green aptamer.29 We first changed the original design of the binary aptamer so that one of the base-paired stems is a four nucleotide GGGG/CCCC stem (Figure 2); this aptamer retains full malachite green binding activity. However, if the 3′-terminal GGGG sequence is shortened to a single G, there is no detectable binding of malachite green. If the 3′-terminal GGGG sequence is shortened to two or three guanosine nucleotides, malachite green binding is reduced, but not eliminated (Figure S1). In the presence of the activated monomer guanosine 5′-monophosphate 2-methylimidazolide (2-MeImpG), non-enzymatic extension of the single 3′-terminal G on the CCCC template regenerates the GGGG/CCCC stem and results in a stable, functional aptamer (Figure 3 and Figure S1). After a 24 h room temperature incubation of 3′-truncated and template strands with 2-MeImpG, the measured malachite green binding was comparable to that of the aptamer assembled from two full-length oligonucleotides (Figure 2C). This experiment shows that inactive functional RNAs, made from oligonucleotides that are truncated at the 3′-end, can be converted to a functional form by non-enzymatic template-directed RNA synthesis.
Hammerhead Ribozyme
Having established that a functional RNA aptamer can be generated by non-enzymatic extension of the 3′-end of one oligonucleotide on a template region of a second oligonucleotide, we investigated the possibility of generating an active ribozyme from two truncated oligonucleotides, each of which could be extended on the other. We chose the hammerhead ribozyme, which cleaves a substrate strand at a defined cleavage site,31 for these experiments. We modified a previously reported minimized consensus sequence so that the ribozyme could be reconstituted from two strands, referred to as “top” and “bottom”.32 These strands form a complex held together by two stems flanking the catalytic loop region (Figure 3).
The top strand, which contains the cleavage site, was labeled at its 5′-end with Cy3. Ribozyme activity was measured by fluorescence-detected polyacrylamide gel electrophoresis (PAGE) gel separation of the full-length fluorescently labeled top strand from the shorter, cleaved product. When we mixed full-length top and bottom strands in equimolar proportions and incubated the resulting complex at room temperature, ribozyme activity was evident from the appearance of cleaved product (65% product in the reaction incubated with 2-MeImpG, Figure 3, and Experimental Section). We then prepared 3′-truncated versions of both the top and bottom strands. Full-length top strand mixed with truncated bottom strand, and truncated top strand mixed with full-length bottom strand, resulted in weak ribozyme activity in both cases. Incubation of the 3′-truncated top and bottom strands resulted in no ribozyme activity (Figure 3). We then examined the effect of incubating the above oligonucleotide mixtures with the activated monomer 2-MeImpG. In the complexes assembled with 3′-truncated oligonucleotides, both strands can act simultaneously as primer and template: the 3′-end of the top strand can be extended by up to 3 guanosine residues (employing the 5′-end of the bottom strand as a template), while the 3′-end of the bottom strand can be extended by up to 4 guanosine residues (employing the 5′-end of the top strand as a template). In all cases, incubation with 2-MeImpG resulted in extension of the 3′-ends of the truncated oligonucleotides and reconstitution of ribozyme activity. In primer extension reactions, if the top 3′-truncated strand was incubated with the bottom full-length strand, 64% cleavage yield was obtained; the top full-length strand incubated with the bottom 3′-truncated strand resulted in 33% product, and if both top and bottom strands were 3′-truncated, 25% product was observed (compared to only 5% background cutting activity by mixing both 3′-truncated strands without 2-MeImpG) (Figure 3). 3′-Truncation of the bottom strand is generally more deleterious than that of the top, likely due to the additional base pair present in the complex of the 3′-truncated top strand with either bottom strand.
Diels–Alderase Ribozyme
Encouraged by the above results, we sought to examine whether a trans-acting ribozyme (i.e., a ribozyme that catalyzes a reaction between two substrates not covalently bound to the ribozyme) could be activated in a similar manner. We started with the minimized sequence of a Diels–Alderase ribozyme,34 which catalyzes a Diels–Alder cycloaddition reaction between a broad range of substrates35 with very good stereoselectivity.36 We redesigned the ribozyme, in this case composed of a single oligonucleotide, to end with the sequence 5′-GGG-3′, which could pair with the internal sequence 5′-CCC-3′ (Figure 4A). We then constructed a set of truncated versions ending in one or two 3′-G residues, which we expected to be less active than the full-length ribozyme.
We followed the reaction between the substrates N-propylmaleimide and 9-hydroxymethylanthracene by HPLC. The background (i.e., uncatalyzed) reaction, in the absence of the catalyst, resulted in conversion of 11% of the anthracene substrate to product in 30 min, and 26% in 1 h. The truncated ribozyme ending in a single 3′-G did not result in any significant increase in product formation, while the full-length ribozyme yielded 72% product in 30 min and 88% in 1 h. A synthetic ribozyme variant ending in two 3′-G residues had intermediate activity (Figure S2).
In order to assess the ability of non-enzymatic primer-extension to convert the inactive truncated ribozyme ending in a single 3′-G residue to an active ribozyme, we incubated the truncated ribozyme with the activated monomer 2-MeImpG for 24 h. The resulting extended ribozyme was nearly as effective a catalyst as the full-length ribozyme, converting 65% of substrates in 30 min and 78% in 1 h (Figure 4).
Discussion
Our observations indicate that functional ribozymes can be generated from non-functional sets of short RNA oligonucleotides by using non-enzymatic template-directed RNA synthesis to convert unstable and inactive oligonucleotide complexes into stable active assemblies. We have used three separate model systems to show that inactive sets of 3′-truncated oligonucleotides can be converted to active aptamers or ribozymes following incubation with the activated monomer 2-MeImpG. In each case, the 3′-end of one or more oligonucleotides was extended by non-enzymatic template-directed primer extension, converting a very weakly base-paired stem (generally a single base-pair) into a stable base-paired stem consisting of four G:C pairs. As a result, the functionally relevant structure was stabilized, and binding or catalytic activity appeared.
We suggest that the first ribozymes may have originated within protocells in a similar three-step process. First, multiple short RNA fragments replicated within protocells by non-enzymatic template-directed RNA synthesis. These RNAs would have been generated in higher-yield than full-length RNAs, owing both to their lowered propensity to fold and the higher efficiency of copying short RNAs non-enzymatically. Second, subsets of these short RNA oligonucleotides assembled into inactive ribozyme precursors. Third, non-enzymatic RNA copying chemistry (potentially the same chemistry that generated the initial fragments) extended the 3′-ends of the ribozyme precursor oligonucleotides, using other regions of RNA in the transient complex as templates, yielding fully functional stable ribozyme complexes. As a result of such a scenario, short, nonfunctional RNAs could afford a protocell vesicle fitness, given their ability to assemble into transient complexes and undergo subsequent primer extension to elaborate these complexes into full-length functional RNAs. As we have recently demonstrated non-enzymatic primer extension inside fatty acid vesicles, such a scenario seems highly plausible.13 Additional support for our hypothesis is provided by recent results demonstrating that Fe2+ can substitute for Mg2+ in functional RNAs, suggesting that the low solubility of Mg2+ in the presence of certain counterions, such as phosphate, may not have been as problematic as anticipated, given the high availability of soluble iron prior to the Great Oxidation Event.37 While our system incorporates only 2-MeImpG, the presence of the other three nucleotide monomers 2-MeImpA, 2-MeImpC, and 2-MeImpU does not impair aptamer or ribozyme reconstitution (Figures S3 and S4), demonstrating that even prebiotically plausible levels of nonenzymatic replication fidelity allow for functional RNA reconstitution via this mechanism.
Given the enhanced thermal stability of the products of primer extension (Figure S5) and increases in aptamer and ribozyme activity with increasing stem length (Figures S1 and S2), it is likely that these RNAs develop function as a result of stabilization of critical structural stems. It is also possible that some of the enhanced function observed in the RNAs occurs as a result of these lengthened homopolymeric stems directing the RNA to assume the correct fold. Both such results would occur as a direct result of the extension of truncated stems.
Our observations have significant implications with regard to two aspects of the evolution of functional RNAs in early cells. First, our results suggest a natural way in which genomic RNA fragments, which must be replicated to enable heritability, can be shorter than the RNAs that actually assemble into functional complexes. Multiple previous examples have shown that aptamers and ribozymes can often be reconstituted from relatively short oligonucleotides.23,24,38,39 This alone shows that primitive RNA replication systems, whether chemical or ribozyme-catalyzed, need only be sufficient to copy fairly short pieces of RNA. However, since primordial non-enzymatic replication systems are expected to be slow and inefficient, and, in fact, no robust copying system has yet been demonstrated experimentally, it remains useful to consider scenarios in which the length of genomic RNAs can be further minimized. Our results suggest that genomic RNA fragments could be at least 3–4 nucleotides shorter than functional RNA fragments, further ameliorating the difficulty associated with primitive RNA replication. Thus, the process we describe for synthesis of functional RNAs relaxes the requirements for prebiotic RNA copying efficiency.
The second aspect of primitive RNA replication that is facilitated by the scenario outlined above has to do with the conflict between the requirements for a good template as opposed to those of a good catalyst. Optimal templates should be completely unfolded, with no internal structure to impede the synthesis of a complementary strand. Similarly, a good template should not be sequestered within a stable complex with other oligonucleotides. In contrast, a good ribozyme must have a stable folded structure, and if the ribozyme is generated through the association of two or more oligonucleotides, the resulting complex should also be a stable structure. This conflict is partially resolved through the strategy of assembling functional complexes from sets of relatively unstructured oligonucleotides; however, in order to allow for uncomplexed templates and functional complexes to co-exist, the affinity of the oligonucleotides for each other must be quite weak. Such a loose association could make it difficult to form a structurally well-defined complex, although this deserves closer experimental attention. Nonetheless, our observations suggest that nonenzymatic primer-extension may provide a natural way to allow for the co-existence of short unstructured templates, and slightly longer derivative oligonucleotides that form stable, functional complexes. We have previously suggested that randomly positioned 2′–5′ linkages, generated as a consequence of non-enzymatic RNA replication, could also contribute to the distinction between good templates and good ribozymes.40 We suggest that the effects of 2′–5′ linkages could act synergistically with the effects of non-enzymatic primer-extension to produce distinct sets of genomic and functional oligonucleotides in primitive cells. The reaction conditions we have employed generate predominantly 3′–5′ linkages, but the small proportion of 2′–5′ linkages produced could have been beneficial in this regard.41
Experimental Section
Oligonucleotides
All oligonucleotides were obtained from IDT with HPLC purification.
Synthesis of 2-MeImpN
Nucleotide 2-methylimidazolides (2-MeImpN, where N = G, A, C, U) were synthesized as previously described.42
Synthesis of the Product of the Diels–Alder Reaction
The product of the Diels–Alder reaction used in our studies (3) was synthesized, for use as a standard, by refluxing 0.625 g (3 mmol) of 9-hydroxymethylanthracene (1) and 0.390 g (2.8 mmol) of N-propylmaleimide (2) in 15 mL of dry toluene for 14 h. The product was purified by silica gel chromatography with 1:1 hexane:ethyl acetate, and it was obtained as a yellow solid in 71% yield. 1H NMR (400 MHz, CDCl3): δ 7.27 (d, 2H), 7.36 (d, 2H), 7.24 (m, 4H), 5.29 (s, 1H), 5.11 (m, 2H), 4.75 (s, 1H), 3.32 (m, 2H), 3.08 (m, 2H), 1.63 (s, 1H), 0.86 (m, 2H), 0.495 (t, 3H). 13C NMR (100 MHz, CDCl3): δ 177.34, 177.06, 142.42, 142.40, 139.57, 139.24, 127.15, 127.11, 126.85, 126.76, 125.50, 124.27, 123.35, 122.74, 60.90, 49.56, 48.01, 46.55, 45.86, 40.36, 20.65, 11.15.
General Procedure for Non-enzymatic RNA Polymerization
Non-enzymatic RNA polymerization was initiated by addition of activated RNA monomer(s) to the mixture of 3′-truncated and template oligonucleotides. Specific reaction conditions are given below for each functional RNA system. All reaction mixtures were incubated at room temperature for specified times, desalted using ZipTip C18 pipet tips (Millipore), and analyzed by TBE–urea 20% PAGE.
Malachite Green Aptamer
The binding of malachite green to the aptamer was measured with a SpectraMAX GeminiEM fluorescence plate reader (Molecular Devices) with excitation wavelength 610 nm and emission wavelength 670 nm. The malachite green stock solution was mixed with RNA top and bottom strands to the final concentration of 2 μM malachite green and 1 μM of each strand of the aptamer in 0.25 M Tris-HCl pH 8.0, 0.15 M NaCl.
In RNA primer extension reactions, the RNA strands were mixed with 2-MeImpG to final concentrations of 50 mM 2-MeImpG and 5 μM each RNA strand (i.e., 5 μM of the RNA complex) in 0.25 M Tris-HCl pH 8.0, 0.15 M NaCl, 50 mM MgCl2. After the reaction, samples were desalted using ZipTip C18 pipet tips (Millipore). Samples were eluted from the tip with 1:1 acetonitrile:water, solvent was removed on a SpeedVac vacuum concentrator, and the RNA was dissolved in water. The concentration of the sample was measured using a NanoDrop spectrophotometer, adjusted to 2 μM of the RNA complex, and analyzed as shown above.
Hammerhead Ribozyme
Hammerhead ribozyme reactions were initiated by mixing both RNA strands to a final concentration of 2.5 μM each strand, in 0.25 M Tris-HCl pH 8.0, 0.15 M NaCl, 50 mM MgCl2. Reactions where primer extension was performed contained 50 mM 2-MeImpG. Reactions were incubated at room temperature for 24 h. After the reaction, samples were desalted using ZipTip C18 pipet tips (Millipore) and analyzed by TBE–urea 20% PAGE. The reaction yield was calculated as the percentage of the product band intensity relative to the total intensity of all bands on the gel.
Diels–Alderase Catalyzed Reaction
The Diels–Alderase reaction was initiated by mixing 9-hydroxymethylanthracene and N-propylmaleimide to final concentrations of 200 μM 9-hydroxymethylanthracene and 1000 μM N-propylmaleimide, in100 mM Tris-HCl pH 7.5, 100 mM MgCl2, and 300 mM NaCl. The Diels–Alderase ribozyme-catalyzed reactions were performed in the presence of 10 μM RNA. In RNA primer extension reactions, the RNA strands were mixed with 2-MeImpG to final concentrations of 50 mM 2-MeImpG and 5 μM each RNA strand in 0.25 M Tris-HCl pH 8.0, 0.15 M NaCl, 50 mM MgCl2. Reactions were incubated at room temperature for 24 h. After the reaction, samples were desalted using ZipTip C18 pipet tips (Millipore). Samples were eluted from the tip with 1:1 acetonitrile:water, solvent was removed on a SpeedVac vacuum concentrator, and the RNA was dissolved in water. The concentration of the sample was measured using a NanoDrop spectrophotometer, the concentration was adjusted to 10 μM of the RNA complex, and this solution was subjected to the above ribozyme reaction conditions.
The reactions were incubated at room temperature for the reported amount of time and analyzed on an Agilent 1100 Analytical HPLC with a Varian Microsorb-mv 100-8 C18 250 × 4.6 mm column with a gradient of solvent A: 0.1% TFA in H2O, and solvent: B 0.1% TFA in acetonitrile, with UV detection at 260 nm.
Acknowledgments
The authors thank Dr. Neha Kamat for helpful discussions and supplying activated nucleotides and members of the Szostak lab for helpful comments on the manuscript. This research was supported in part by a grant from the Simons Collaboration on the Origin of Life to J.W.S. A.E.E. was supported by an appointment to the NASA Postdoctoral Program through NASA Astrobiology, administered by Oak Ridge Associated Universities through a contract with NASA, and a Tosteson Fellowship from the Massachusetts General Hospital Executive Committee on Research. J.W.S. is an Investigator of the Howard Hughes Medical Institute.
Supporting Information Available
Supplementary discussion and Figures S1–S5. This material is available free of charge via the Internet at http://pubs.acs.org.
Author Present Address
† K.A.: MIT Media Lab and McGovern Institute, Departments of Biological Engineering and Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139
The authors declare no competing financial interest.
Supplementary Material
References
- Gilbert W. Nature 1986, 319, 618. [Google Scholar]
- Orgel L. E. Crit. Rev. Biochem. Mol. Biol. 2004, 39, 99. [DOI] [PubMed] [Google Scholar]
- Robertson M. P.; Joyce G. F. Cold Spring Harb. Perspect. Biol. 2012, 4, a003608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guerrier-Takada C.; Gardiner K.; Marsh T.; Pace N.; Altman S. Cell 1983, 35, 849. [DOI] [PubMed] [Google Scholar]
- Zaug A. J.; Cech T. R. Science 1986, 231, 470. [DOI] [PubMed] [Google Scholar]
- Ban N.; Nissen P.; Hansen J.; Moore P. B.; Steitz T. A. Science 2000, 289, 905. [DOI] [PubMed] [Google Scholar]
- Wilson D. S.; Szostak J. W. Annu. Rev. Biochem. 1999, 68, 611. [DOI] [PubMed] [Google Scholar]
- Talini G.; Gallori E.; Maurel M. C. Res. Microbiol. 2009, 160, 457. [DOI] [PubMed] [Google Scholar]
- Weimann B. J.; Lohrmann R.; Orgel L. E.; Schneider-Bernloehr H.; Sulston J. E. Science 1968, 161, 387. [DOI] [PubMed] [Google Scholar]
- Vogel S. R.; Richert C. Chem. Commun. (Camb.) 2007, 1896. [DOI] [PubMed] [Google Scholar]
- Mansy S. S.; Schrum J. P.; Tobe S.; Krishnamurthy M.; Treco D. A.; Szostak J. W. Nature 2008, 122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deck C.; Jauker M.; Richert C. Nat. Chem. 2011, 3, 603. [DOI] [PubMed] [Google Scholar]
- Adamala K.; Szostak J. W. Science 2013, 342, 1098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szostak J. W. J. Syst. Chem. 2012, 3, 2. [Google Scholar]
- Hey M.; Gobel M. Methods Mol. Biol. 2005, 288, 305. [DOI] [PubMed] [Google Scholar]
- Vogel S. R.; Deck C.; Richert C. Chem. Commun. (Camb.) 2005, 4922. [DOI] [PubMed] [Google Scholar]
- Inoue T.; Orgel L. E. J. Am. Chem. Soc. 1981, 103, 7666. [Google Scholar]
- Green R.; Szostak J. W. Science 1992, 258, 1910. [DOI] [PubMed] [Google Scholar]
- Zamel R.; Poon A.; Jaikaran D.; Andersen A.; Olive J.; De Abreu D.; Collins R. A. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Canny M. D.; Jucker F. M.; Kellogg E.; Khvorova A.; Jayasena S. D.; Pardi A. J. Am. Chem. Soc. 2004, 126, 10848. [DOI] [PubMed] [Google Scholar]
- Chadalavada D. M.; Gratton E. A.; Bevilacqua P. C. Biochemistry 2010, 49, 5321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doudna J. A.; Couture S.; Szostak J. W. Science 1991, 251, 1605. [DOI] [PubMed] [Google Scholar]
- Hayden E. J.; Lehman N. Chem. Biol. 2006, 13, 909. [DOI] [PubMed] [Google Scholar]
- Butcher S. E.; Heckman J. E.; Burke J. M. J. Biol. Chem. 1995, 270, 29648. [DOI] [PubMed] [Google Scholar]
- Guerrier-Takada C.; Altman S. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galloway Salvo J. L.; Coetzee T.; Belfort M. J. Mol. Biol. 1990, 211, 537. [DOI] [PubMed] [Google Scholar]
- Jarrell K. A.; Dietrich R. C.; Perlman P. S. Mol. Cell. Biol. 1988, 8, 2361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grate D.; Wilson C. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 6131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kolpashchikov D. M. J. Am. Chem. Soc. 2005, 127, 12442. [DOI] [PubMed] [Google Scholar]
- Flinders J.; DeFina S. C.; Brackett D. M.; Baugh C.; Wilson C.; Dieckmann T. ChemBioChem 2004, 5, 62. [DOI] [PubMed] [Google Scholar]
- Birikh K. R.; Heaton P. A.; Eckstein F. Eur. J. Biochem. 1997, 245, 1. [DOI] [PubMed] [Google Scholar]
- Uhlenbeck O. C. Nature. 1987, 328, 596. [DOI] [PubMed] [Google Scholar]
- Breslow R.; Huang D. L.; Anslyn E. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 1746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seelig B.; Jaschke A. Chem. Biol. 1999, 6, 167. [DOI] [PubMed] [Google Scholar]
- Stuhlmann F.; Jaschke A. J. Am. Chem. Soc. 2002, 124, 3238. [DOI] [PubMed] [Google Scholar]
- Schlatterer J. C.; Stuhlmann F.; Jaschke A. ChemBioChem 2003, 4, 1089. [DOI] [PubMed] [Google Scholar]
- Athavale S. S.; Petrov A. S.; Hsiao C.; Watkins D.; Prickett C. D.; Gossett J. J.; Lie L.; Bowman J. C.; O’Neill E.; Bernier C. R.; Hud N. V.; Wartell R. M.; Harvey S. C.; Williams L. D. PloS One 2012, 7, e38024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Isomoto N.; Maeda Y.; Tanaka T.; Furuta H.; Ikawa Y. J. Mol. Evol. 2013, 76, 48. [DOI] [PubMed] [Google Scholar]
- Whoriskey S. K.; Usman N.; Szostak J. W. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 2465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Engelhart A. E.; Powner M. W.; Szostak J. W. Nat. Chem. 2013, 5, 390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inoue T.; Orgel L. E. J. Mol. Biol. 1982, 162, 201. [DOI] [PubMed] [Google Scholar]
- Joyce G. F.; Inoue T.; Orgel L. E. J. Mol. Biol. 1984, 176, 279. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.